Basic Information
| LncRNA/CircRNA Name | CACNA1G-AS1 |
| Synonyms | NA |
| Region | GRCh38_17:50556207-50562108 |
| Ensemble | ENSG00000250107 |
| Refseq | NR_038439 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR |
| Sample | HCC tissues |
| Expression Pattern | up-regulated |
| Function Description | Through bioinformatics analysis, we found that CACNA1G-AS1 expression was significantly upregulated in HCC tissues compared with that in the adjacent normal tissues. |
| Pubmed ID | 30908634 |
| Year | 2019 |
| Title | LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway. |
External Links
| Links for CACNA1G-AS1 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |